Baghdad: US President Donald Trump confirmed that he is open to making deals with countries on tariffs, but these agreements will have to be negotiated after the announcement of counter-tariffs on April 2. Speaking to reporters aboard Air Force One, Trump also said that he will soon announce tariffs targeting the pharmaceutical industry.

According to National Iraqi News Agency, Trump emphasized the importance of fair trade agreements and suggested that the current tariffs are a step towards achieving balanced trade relationships. The announcement of potential deals on tariffs suggests a willingness to engage in dialogue with international trade partners, provided that these negotiations take place post the counter-tariffs implementation.

Trump’s mention of upcoming tariffs on the pharmaceutical industry indicates a new focus area for his administration’s trade policy. This move could have significant implications for international pharmaceutical companies and potentially impact drug prices and availability.

The administration’s approach to tariffs and trade deals continues to be a central aspect of Trump’s economic strategy, with ongoing discussions expected to address various sectors and international trade dynamics.